Roche On Track To Supplement Relaunched Susvimo’s Label

DME
Roche hopes to add two diabetes-related eye diseases to the Susvimo label • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D